Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | Visfatin | 1 | ng/mL | 2 | IL-9 | 53.0 | 54 | ||||
N2586 | EO1428 | 1.0 | uM | Visfatin | 1 | ng/mL | 2 | IL-9 | 59.0 | 60 | |
N2586 | PI103 | 0.1 | uM | Visfatin | 1 | ng/mL | 2 | IL-9 | 70.0 | 39 | |
N2586 | Sigma A6730 | 3.0 | uM | Visfatin | 1 | ng/mL | 2 | IL-9 | 70.0 | 34 | |
N2586 | JNK-IN-8 | 3.0 | uM | Visfatin | 1 | ng/mL | 2 | IL-9 | 49.0 | 54 | |
N2586 | JNK-IN-11 | 0.3 | uM | Visfatin | 1 | ng/mL | 2 | IL-9 | 58.0 | 47 | |
0 | IL-9 | 41.5 | 54 | ||||||||
RA2159 | Poly(I:C) | 2 | ug/mL | 2 | IL-9 | 119.5 | 60 | ||||
RA2159 | EO1428 | 1.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-9 | 97.5 | 40 | |
RA2159 | PI103 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-9 | 90.0 | 73 | |
RA2159 | Sigma A6730 | 3.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-9 | 110.0 | 70 | |
RA2159 | JNK-IN-8 | 3.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-9 | 65.0 | 31 | |
RA2159 | JNK-IN-11 | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-9 | 99.0 | 38 | |
N2586 | Poly(I:C) | 2 | ug/mL | 2 | IL-9 | 137.5 | 30 | ||||
N2586 | EO1428 | 1.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-9 | 121.0 | 50 | |
N2586 | PI103 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-9 | 116.0 | 33 | |
N2586 | Sigma A6730 | 3.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-9 | 100.5 | 26 | |
N2586 | JNK-IN-8 | 3.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-9 | 93.0 | 36 | |
N2586 | JNK-IN-11 | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-9 | 93.0 | 50 | |
0 | IL-9 | 53.0 | 71 | ||||||||
RA2159 | Poly(I:C) | 2 | ug/mL | 3 | IL-9 | 110.5 | 88 | ||||
RA2159 | PD184352 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-9 | 126.0 | 65 | |
RA2159 | Lestaurtinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-9 | 90.0 | 66 | |
RA2159 | Ruxolitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-9 | 125.0 | 73 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-9 | 108.0 | 79 |